Table 1.
Relationship between expression of SLPI and its clinic pathological characteristic in colorectal cancer
| Patients | SLPI expression (%) | Χ2 | P | ||
|---|---|---|---|---|---|
| High | Low | ||||
| Sex | 0.013 | 0.871 | |||
| Male | 162 | 76 (46.9) | 86 (53.1) | ||
| Female | 134 | 65 (48.5) | 69 (51.5) | ||
| Age (years) | 0.241 | 0.613 | |||
| >65 | 104 | 49 (47.1) | 55 (52.9) | ||
| <65 | 192 | 101 (52.6) | 91 (47.4) | ||
| Pathologic grade | 38.143 | <0.05 | |||
| Good or moderate | 260 | 253 (97.3) | 7 (2.7) | ||
| Low | 36 | 21 (58.3) | 15 (41.7) | ||
| TNM grade | 19.241 | <0.05 | |||
| I–II | 118 | 113 (95.8) | 5 (4.2) | ||
| III–IV | 178 | 143 (80.3) | 35 (19.7) | ||
| Lymphatic metastasis | 25.174 | <0.05 | |||
| Positive | 129 | 105 (81.4) | 24 (18.6) | ||
| Negative | 167 | 164 (98.2) | 3 (1.8) | ||
| Distal metastasis | 31.247 | <0.05 | |||
| Positive | 37 | 5 (13.5) | 32 (86.5) | ||
| Negative | 259 | 232 (89.6) | 27 (10.4) | ||